Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-08-15
2006-08-15
Pryor, Alton (Department: 1616)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S212080, C514S236200
Reexamination Certificate
active
07091203
ABSTRACT:
The invention relates to imidazo[1,3,5]triazinones, a method for their production and methods of use, in particular as inhibitors of cyclic GMP metabolizing phosphodiesterases.
REFERENCES:
patent: 5482941 (1996-01-01), Terrett
patent: 5591742 (1997-01-01), Bell et al.
patent: 6362178 (2002-03-01), Niewöhner et al.
patent: 6803365 (2004-10-01), Niewohner et al.
patent: 0463756 (1992-01-01), None
patent: 0951908 (1999-10-01), None
patent: 9428902 (1994-12-01), None
patent: 9719947 (1997-06-01), None
patent: 9849166 (1998-11-01), None
Golankiewicz, B., et al., “Synthesis and Antiviral Activity of Benzyl-Substituted Imidazo[1,5-a]-1,3,5-triazine (5,8-Diaza-7.9-dideazapurine) Derivatives,” J. Med.Chem., 38(18):3558-3565 (1995).
Golankiewicz, B., et al., “The Route from 4-Oxo- to 4-Amino-imidazo[1,5-a]-1,3,5-triazines and the Tautomerism of 4-Oxo, 4-Thioxo and 4-Oxo-2-thioxo Derivatives. A1H and13C NMR and X-Ray Crystollographic Study,” J. Chem. Res. Synop., (3): 96-97 (1994).
Golankiewicz, B., et al., “Synthesis of Imidazo[1,5-a]-1,3,5-triazinones by Cyclization-Rearrangement,” J. Org. Chem., 44(10): 1740-1742 (1979).
Golankiewicz, B., et al., “Synthesis and Biological Activity of C-Acyclic Nucleosides of Imidazo [1,5-a]-1,3,5-Triazines,” Nucleosides and Nucleotides, 6(4): 663-678 (1987).
Holtwick, J.B., et al., “Guanine, Hypoxanthine, and Xanthine Analogues. Synthesis of Imidazol[1,5-a]-1,3,5-triazinones via Rearrangement,” J. Org. Chem., 44(22): 3835-3839 (1979).
Holtwick, J.B., et al., “Guanine Analogues. Allyl-Substituted Aminoimidazo[1,5-a]-1,3,5-triazinones Formed by Cyclization-Rearrangement,” J. Org. Chem., 46(18): 3681-3685 (1981).
Wang, Y., et al., “Antitumor Imidazotetrazines. Part 36. Conversion of 5-amino-imidazole-4-carboxamide to imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-ones and imidazol[1,5-a][1,3,5]triazin-4(3H)-ones related in structure to the antitumor agents temozolomide and mitozolomide,” J. Chem. Soc., Perkin Trans. 1, pp. 1669-1675 (1998).
Wang, Y., et al., “Synthetic Studies of 8-Carbamoylimidazo-[5,1-D]-1,2,3,5-Tetrazin-4(3H)-one: A Key Derivative of Antitumor Drug Temozolomide,” Bioorganic & Medicinal Chemistry Letters, 6(2): 185-188 (1996).
Beavo, J., et al., “Primary Sequence of Cyclic Nucleotide Phosphodiesterase Isozymes-and the Design of Selective Inhibitors,” TIPS Reviews, 11: 150-155 (1990).
Rao, T., et al, “Synthesis of Certain Acyclic Nucleoside Analogs of 1,2,4-Triazolo[3,4-ƒ][1,2,4]Triazine and Pyrimido[5,4-d]Pyrimidine,” Nucleosides and Nucleotides, 14(7): 1601-1612 (1995).
Bhattacharya, B., et al., “Synthesis of Certain N- and C-Alkyl Purine Analogs,” J. Heterocyclic Chem., 30(5): 1341-1349 (1993).
Mitchell, W., et al., “Synthesis of C-Nucleoside Isosteres of 9-(2-Hydroxyethoxymethyl) Guanine (Acyclovir) [1],” J. Heterocyclic Chem., 21(3): 697-699 (1984).
Stoclet, J., et al., “Cyclic Nucleotide Phosphodiesterases as Therapeutic Targets in Cardiovascular Diseases,” Exp. Opin. Invest. Drugs, 4(11): 1081-1100 (1995).
Kobe, et al., “Use of Distance Geometry Approach for the In Vitro Antiviral Activity Evaluation of N-Bridgehead C-Nucleosides,” Eur. J. Med. Chem., 27(3): 259-266 (1992).
Golankiewicz, B., et al., “Synthesis and Antiviral of Benzyl-Substituted Imidazo[1,5-a]-1,3,5-triazine (5,8-Diaza-7.9-dideazapurine) Derivatives,” J. Med.Chem., 39: 624 (1996).
Bischoff Erwin
Dembowsky Klaus
Es-Sayed Mazen
Haning Helmut
Lampe Thomas
Bayer Healthcare AG
Pellegrino Susan M.
Pryor Alton
LandOfFree
Imidazo[1,3,5]triazinones and their use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazo[1,3,5]triazinones and their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazo[1,3,5]triazinones and their use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3693813